Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

124
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
124
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

506
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
506
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Guidelines for Nursing Documentation II01:26

Guidelines for Nursing Documentation II

1.1K
Effective documentation is an integral part of nursing practice. Here are some essential guidelines to follow when documenting patient care:
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
1.1K
Guidelines for Nursing Documentation I01:30

Guidelines for Nursing Documentation I

1.1K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:  
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
1.1K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

18
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
18

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Hippocampus Links Episodic Memory and Bodily Awareness.

Brain and behavior·2026
Same author

Family caregiver perspectives on administering home-based stimulation in patients with mild cognitive impairment.

Journal of Alzheimer's disease : JAD·2026
Same author

[Agitation in neuropsychiatric symptoms of dementia : beyond drugs].

Revue medicale suisse·2026
Same author

Cognitive adaptations for memory deficits in MCI and AD patients: A meta-analysis of EEG microstates.

NeuroImage. Clinical·2026
Same author

Hippocampal Subfield Susceptibility Alterations in Mild Cognitive Impairment Revealed by 7T MRI.

AJNR. American journal of neuroradiology·2025
Same author

Subjective Cognitive Decline, Inter-Personal Attachment Style and Relationship Quality.

Journal of general and family medicine·2025

Related Experiment Video

Updated: Jul 15, 2025

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

14.9K

[Dementia : current guidelines for clinical management].

Mohamed Eshmawey1, Salem Boudouh1, Paul G Unschuld1

  • 1Service de psychiatrie gériatrique, Département de psychiarie, Hôpital de Belle-Idée, Hôpitaux universitaires de Genève, Chemin du Petit Bel-Air, 1226 Thônex.

Revue Medicale Suisse
|October 4, 2023
PubMed
Summary

Dementia describes cognitive decline interfering with daily life, often caused by Alzheimer's disease (AD). New monoclonal antibody therapies show promise for soon modulating AD disease progression.

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.4K

Related Experiment Videos

Last Updated: Jul 15, 2025

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

14.9K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.4K

Area of Science:

  • Neurology
  • Geriatrics
  • Pharmacology

Context:

  • Dementia is a syndrome characterized by cognitive decline impacting daily functioning.
  • Alzheimer's disease (AD) is the most common cause, but other conditions contribute to dementia in older adults.
  • Current management focuses on symptom relief and daily life support.

Purpose:

  • To provide an overview of dementia as a syndrome.
  • To discuss current treatment approaches for dementia symptoms.
  • To highlight emerging therapeutic strategies for Alzheimer's disease.

Summary:

  • Dementia encompasses a range of symptoms causing significant cognitive decline and functional impairment.
  • While Alzheimer's disease is a primary cause, dementia is a syndrome with diverse underlying pathologies.
  • Treatment strategies address cognitive deficits, behavioral issues, sleep disturbances, and daily living challenges.

Impact:

  • Effective dementia management requires a personalized approach to address multifaceted patient needs.
  • Emerging monoclonal antibody therapies offer potential for disease-modifying treatments in Alzheimer's disease.
  • Advancements in neurobiological understanding may lead to treatments that can alter disease progression.